Analyzing Auna (NYSE:AUNA) & biote (NASDAQ:BTMD)

Auna (NYSE:AUNA – Get Free Report) and biote (NASDAQ:BTMD – Get Free Report) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, dividends and valuation.

Analyst Recommendations

This is a summary of current ratings for Auna and biote, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Auna 1 2 1 1 2.40
biote 1 1 1 1 2.50

Auna presently has a consensus target price of $6.97, suggesting a potential upside of 90.87%. biote has a consensus target price of $2.50, suggesting a potential upside of 205.25%. Given biote’s stronger consensus rating and higher probable upside, analysts plainly believe biote is more favorable than Auna.

Volatility & Risk

Auna has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500. Comparatively, biote has a beta of 1.73, indicating that its stock price is 73% more volatile than the S&P 500.

Profitability

This table compares Auna and biote’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Auna 0.44% 12.88% 3.24%
biote -1.08% -8.61% 4.61%

Insider and Institutional Ownership

21.7% of biote shares are held by institutional investors. 32.4% of biote shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Auna and biote”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Auna $1.23 billion 0.22 $27.39 million ($0.04) -91.25
biote $192.22 million 0.15 $27.05 million ($0.10) -8.19

Auna has higher revenue and earnings than biote. Auna is trading at a lower price-to-earnings ratio than biote, indicating that it is currently the more affordable of the two stocks.

Summary

biote beats Auna on 7 of the 13 factors compared between the two stocks.

About Auna

(Get Free Report)

Auna S.A. is a Latin American healthcare company that provides medical care through a network of hospitals, clinics and specialized treatment centers. Its services include general and specialty care, diagnostic services and cancer treatment. The company also offers health plans and other healthcare financing services, integrating coverage with care delivery. Auna serves patients in Peru, Colombia and Mexico.

About biote

(Get Free Report)

Biote is a medical technology and services company focused on hormone optimization. It supports healthcare providers who offer bioidentical hormone replacement therapy (BHRT), including pellet-based treatment programs for eligible patients. The company’s services include provider training and education, patient and practice support, and hormone testing and treatment protocols. Biote also offers nutritional supplements and related wellness products through participating providers. Biote was founded in 2012 and serves a network of healthcare providers in the United States.

Receive News & Ratings for Auna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Auna and related companies with MarketBeat.com's FREE daily email newsletter.